Inhaled COVID-19 Vaccine Used as Booster in China
Shanghai became the first city to initiate booster vaccination by inhalation for adults aged 18+ using aerosol drug delivery technology from Aerogen.
Tag: aerosol therapy delivery
All
Latest
All
Latest
Triple Therapy Reduces Exacerbations in Severe Asthma
Triple therapy is linked with fewer asthma exacerbations in pediatric and adult populations, according to a new meta-analysis.
All
Latest
Electronic Alert Reduces Excessive Prescribing of Short-acting Asthma Relievers
An automatic, electronic alert on general practitioners' computer screens can help to prevent excessive prescribing of short-acting asthma reliever medication, according to research presented at the virtual European Respiratory Society International Congress.
Albuterol Shortage Looms During Coronavirus Pandemic
As the number of COVID-19 cases grow, hospitals throughout the US are reporting shortages of albuterol, a life saving medication for asthma sufferers.
Read More
Combination Inhaler Therapy Decreases COPD Deaths
A once-daily inhaler combination of fluticasone furoate, umeclidinium and vilanterol reduced overall mortality in patients with chronic obstructive pulmonary disease (COPD) by 42%.
Read More
Young Adults Not Sticking to Their ICS Asthma Therapy
Nearly 3-in-4 of emerging adults with asthma do not adhere to their prescribed inhaled corticosteroid therapy, according to a study published in the Journal of Asthma.
Read More
BiPAP Ventilation is Safe for Pediatric Asthma Patients, Study Shows
A study published in the Journal of the Formosan Medical Association found that bilevel positive airway pressure (BiPAP) ventilation is safe for improving respiratory rate and oxygenation in asthmatic children.
Read More
Global Study Reveals Asthma Demographics
A survey published in CHEST shows demographic data and clinical characteristics of asthma patients.
Read More
Children With Asthma at Risk for Pneumococcal Disease
Children with asthma are at much greater risk for invasive pneumococcal disease (IPD), even if they have received the pneumococcal conjugate vaccine (PCV), a systematic review and meta-analysis have found.
Read More
Novartis Drops Asthma Drug Fevipiprant After Trial Failures
Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after the medicine failed another set of key trials.
Read More
10 Tips to Reduce Unnecessary Pediatric MDI and Aerosol Treatments
Chronic lung conditions such as asthma require aerosolized pharmacological maintenance therapy, but data suggests the frequency and dosages can often be overprescribed and based on empirical assumptions rather than clinical evidence.
Read More
Asthma Patients Could Slash Their Carbon Footprint by Switching to ‘Greener’ Inhalers
Asthma patients could sharply reduce their carbon footprint by swapping commonly used...
Read More
Abruptly Changing Child’s Asthma Inhaler May Reduce Lung Function
Children with asthma who are required to switch inhaler types to accommodate insurance formulary changes may experience a loss of lung function not seen in children whose inhaler type stayed the same.
Read More
Triple Combo Inhaler Had Positive Asthma Results
In patients with uncontrolled asthma, a LAMA combined with an ICS and LABA in a single inhaler improved FEV1 and reduced exacerbations, according to data presented at ERS 2019.
Read More
Study: Children With Mild Asthma Can Use Inhalers As Needed
A study from Washington University School of Medicine in St. Louis supports evidence that children...
Read More